Pain perception after subcutaneous injections of media containing different buffers

Basic and Clinical Pharmacology and Toxicology

Volumn 98, Issue 2, 2006, Pages 218-221

  Laursen, Torben ^b   Hansen, Birtha ^a   Fisker, Sanne ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; CITRIC ACID; HISTIDINE; HUMAN GROWTH HORMONE; ISOTONIC SOLUTION; SODIUM CHLORIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; INJECTION SITE PAIN; MALE; NOCICEPTION; NORMAL HUMAN; NURSE; PAIN ASSESSMENT; PATIENT COMPLIANCE; PH; PRIORITY JOURNAL; THIGH;

ADULT; BUFFERS; CITRIC ACID; DOUBLE-BLIND METHOD; FEMALE; HISTIDINE; HUMAN GROWTH HORMONE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; PAIN; PAIN MEASUREMENT;

EID: 33645073012     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_271.x     Document Type: Article

References (14)

1. Cheney P. R. G. Molzen D. Tandberg The effect of pH buffering on reducing the pain associated with subcutaneous infiltration of bupivacaine Amer. J. Emergency Med. 1991 9 147 148
2. Fransson J. A. Espander-Jansson Local tolerance of subcutaneous injections J. Pharm. Pharmacol. 1996 48 1012 1015
3. Frenken L. A. H. J. van Lier J. G. Jordans K. M. Leunissen R. van Leusen V. M. Verstappen R. A. Koene Identification of the component part in an epoetin alfa preparation that causes pain after subcutaneous injection Amer. J. Kidney Dis. 1993 22 553 556
4. Grond S. T. Meuser D. Zech U. Hennig K. A. Lehmann Analgesic efficacy and safety of tramadol enantiomers in comparison with the racemate: a randomised, double-blind study with gynaecological patients using intravenous patient-controlled analgesia Pain 1995 62 313 320
5. Jørgensen J. T. Improvement of patient convenience in treatment with growth hormone J. Pediat. Endocrinol. 1994 7 175 180
6. Kappelgaard A.-M. A. Bojesen K. Skydsgaard I. Sjögren T. Laursen Liquid Growth Hormone: Preservatives and Buffers Hormone Res. 2004 62 suppl. 3 98 103
7. Laursen T. J. O. Jørgensen S. Susgaard J. Moller J. S. Christiansen Subcutaneous absorption kinetics of two highly concentrated preparations of recombinant human growth hormone Ann. Pharmacotherapy 1993 27 411 415
8. ®: a liquid human growth hormone formulation, a pen system and an auto-insertion device Hom. Res. 1999 51 suppl. 3 109 112
9. Rasmussen L. H. M. Zachmann P. Nielsson Authentic recombinant human growth hormone (GH). Results of a multicenter clinical trial in patients with GH-deficiency Helv. Paediatr. Acta 1989 43 443 448
10. Scarfone R. J. M. Jasani E. J. Gracely Pain of local anesthetics: rate of administration and buffering Ann. Emergency Med. 1998 31 36 40
11. Svendsen O. J. Carstensen Antimicrobial excipients and local damage at injection sites J. Vet. Pharmacol. Therap. 1997 20 suppl. 1 252 293
12. Vahl N. S. B. Jensen M. H. Rasmussen S. Susgaard J. O. Jørgensen J. S. Christiansen U. F. Rasmussen J. Hilsted Bioavailability of recombinant human growth hormone in different concentrations and formulations Pharmacology & Toxicology 1996 79 144 149
13. Veys N. A. Dhondt N. Lameire Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta Clin. Nephrol. 1998 49 41 44
14. Yu A. W. C. B. Leung P. K. Li S. F. Lui K. N. Lai Pain perception following subcutaneous injections of citrate-buffered and phosphate-buffered epoetin alpha Int. J. Artif. Organs 1998 21 341 343